Tag: companion animal arthritis market outlook

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Companion Animal Arthritis Market Poised To Hit $6.62 Billion By 2030 With A 10.2% CAGR

The companion animal arthritis market size has seen rapid growth in recent years. It is projected to expand from $4.07 billion in 2025 to $4.48 billion in 2026, at a compound annual growth rate (CAGR) of 10.1%. The market’s historical growth can be attributed to an increase in companion animal ownership, the extended lifespans of dogs and cats, rising awareness of pet joint health, the expansion of veterinary care infrastructure, and the availability of anti-inflammatory medications.

The companion animal arthritis market is projected to experience substantial expansion over the coming years. This market is forecast to reach a valuation of $6.62 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.2%. Factors contributing to this growth include escalating pet humanization tendencies, a greater need for sophisticated arthritis treatments, an expanding population of older pets, the proliferation of online veterinary pharmacies, and advancements in combination therapies and nutritional supplements. Key trends anticipated during the forecast timeframe encompass a rising incidence of age-related arthritis among pets, increased expenditure by pet owners on chronic conditions, wider acceptance of nutraceuticals and joint supplements, a move towards prompt diagnosis and proactive care, and a growing requirement for enduring pain relief strategies.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=7772&type=smp&name=Companion%20Animal%20Arthritis%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Companion Animal Arthritis Market Opportunity Drivers: What’s Unlocking New Revenue Potential?

The increasing inclination towards pet adoption is anticipated to drive expansion within the companion animal arthritis market. This practice involves acquiring a pet from an animal shelter or its former owner, then committing to provide it with proper care, nourishment, and a secure living environment. The uptick in pet adoption stems from heightened emotional consciousness, as an increasing number of individuals pursue companionship and enhance their mental well-being by looking after animals. Treatments for companion animal arthritis facilitate pet adoption by assuring prospective owners that age-related joint problems are manageable, thereby simplifying the care of older pets and boosting their adoptability. An illustrative example from 2024, data from Shelter Animals Count (SAC), a US-based nonprofit organization, shows that dog adoption rates (defined as the percentage of adoptions compared to intakes) climbed from 56% in 2023 to 57% in 2024. Consequently, the expanding trend of pet adoption plays a substantial role in the development of the companion animal arthritis market.

Companion Animal Arthritis Market Breakdown By Product Type And Application

The companion animal arthritis market covered in this report is segmented –

1) By Type: Dogs, Cats, Other Types

2) By Indication: Osteoarthritis, Inflammatory Arthritis

3) By Treatment: Medication, Supplements, Other Treatments

4) By Distribution Channel: Veterinary Hospitals And Clinics, Retail Pharmacies, Online Stores, Other Distribution Channels

Subsegments:

1) By Dogs: Large Breed Dogs, Small Breed Dogs, Senior Dogs

2) By Cats: Domestic Cats, Senior Cats

3) By Other Types: Rabbits, Ferrets

Companion Animal Arthritis Market Innovation Trends Shaping Future Development

Major companies in the companion animal arthritis market are increasingly concentrating on technological breakthroughs, such as advanced therapeutic items and supplements, aimed at providing pets with effective pain relief and improved joint health, ultimately ensuring a better quality of life for aging and arthritis-affected animals. Bonqat is a novel medicine developed for cats to help alleviate anxiety during stressful situations, including travel or veterinary visits, without causing sedation. The product seeks to calm cats, simplifying experiences for them and their owners during excursions or appointments. For instance, in April 2024, Zoetis Inc., a US-based company manufacturing medicines and vaccinations for pets and livestock, launched Bonqat (pregabalin oral solution) to relieve feline acute anxiety and fear associated with transportation and veterinary visits, which can often hinder routine care. This oral solution can be mixed with food or given directly to the cat, making administration easier for pet owners. The dosage is small (0.1 mL/kg), and a majority of cat owners have reported simple administration.

Companion Animal Arthritis Market Leading Players And Competitive Positioning

Major companies operating in the companion animal arthritis market are Zoetis Inc., Merck Animal Health, Boehringer Ingelheim, Bayer Animal Health, Vetoquinol, Ceva Santé Animale, Dechra Pharmaceuticals, PetMed Express, Pet Health Solutions, VetriScience, Canine Arthritis Management, Integrative Pet Care, The Honest Kitchen, Vetri-Science Laboratories, Anivive Lifesciences, Nutramax Laboratories, Hill’s Pet Nutrition, Royal Canin, Medivet, Virbac, Canna-Pet, Lintbells, Allivet, Petlab Co.

View The Full Companion Animal Arthritis Market Report:

https://thebusinessresearchcompany.com/report/companion-animal-arthritis-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Companion Animal Arthritis Market Regional Distribution: Which Areas Power Market Growth?

North America was the largest region in the companion animal arthritis market in 2025. The regions covered in the companion animal arthritis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Alpha Mannosidosis Market Projected To Become By 2030 Based On Its 2026 Valuation?

The companion animal arthritis market has experienced significant expansion in recent years. This market is projected to grow from $4.07 billion in 2025 to $4.48 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.1%. Historically, this growth can be attributed to an increase in companion animal ownership, the extended lifespans of dogs and cats, rising awareness of pet joint health, the expansion of veterinary care infrastructure, and the availability of anti-inflammatory medications.

The companion animal arthritis market size is set to experience substantial expansion over the next few years. It is forecast to reach a valuation of $6.62 billion by 2030, achieving a compound annual growth rate (CAGR) of 10.2%. This anticipated growth during the forecast period stems from factors such as increasing pet humanization trends, a rising demand for advanced arthritis therapies, an expanding senior pet population, the proliferation of online veterinary pharmacies, and breakthroughs in combination therapies and supplements. Significant trends foreseen in this period include a growing prevalence of age-related arthritis in pets, increased spending by pet owners on chronic care, wider adoption of nutraceuticals and joint supplements, a move towards early diagnosis and preventive treatment, and a heightened need for long-term pain management solutions.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7772&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Alpha Mannosidosis Market?

The increasing rate of pet adoption is anticipated to fuel expansion within the companion animal arthritis market. Pet adoption involves assuming care for an animal from a shelter or prior owner, encompassing the provision of nourishment, shelter, and overall well-being. The surge in pet adoption stems from heightened emotional consciousness, with individuals increasingly seeking companionship and mental solace through animal care. Treatments for companion animal arthritis facilitate pet adoption by assuring prospective owners that age-related joint problems are manageable, thereby simplifying the care of older pets and enhancing their chances of adoption. An example highlighting this trend is seen in 2024, where data from the US-based nonprofit Shelter Animals Count (SAC) indicates that dog adoption rates (calculated as a percentage of adoptions against intakes) rose from 56% in 2023 to 57% in 2024. Consequently, the escalating trend of pet adoption plays a crucial role in fostering the expansion of the companion animal arthritis market.

What Segment Groups Are Identified Within The Alpha Mannosidosis Market?

The companion animal arthritis market covered in this report is segmented –

1) By Type: Dogs, Cats, Other Types

2) By Indication: Osteoarthritis, Inflammatory Arthritis

3) By Treatment: Medication, Supplements, Other Treatments

4) By Distribution Channel: Veterinary Hospitals And Clinics, Retail Pharmacies, Online Stores, Other Distribution Channels

Subsegments:

1) By Dogs: Large Breed Dogs, Small Breed Dogs, Senior Dogs

2) By Cats: Domestic Cats, Senior Cats

3) By Other Types: Rabbits, Ferrets

What Trends Are Advancing Progress In The Companion Animal Arthritis Market?

Companies within the companion animal arthritis market are increasingly concentrating on technological breakthroughs, including sophisticated therapeutic items and supplements, to offer effective pain relief and better joint health for pets, thereby enhancing the life quality for older and arthritis-afflicted animals. Bonqat represents a novel medication specifically for cats, designed to alleviate anxiety during stressful events like travel or veterinary appointments, without inducing drowsiness. Its objective is to soothe cats, simplifying experiences such as journeys or medical visits for both the animals and their owners. For example, in April 2024, Zoetis Inc., a US-based firm producing medicines and vaccinations for animals, introduced Bonqat (pregabalin oral solution) to mitigate acute anxiety and fear in felines linked to transportation and veterinary visits, factors that often impede regular care. This oral solution can be combined with food or given straight to the cat, simplifying the administration process for pet owners. The dosage is minimal (0.1 mL/kg), and most cat owners have indicated that administering it is straightforward.

Which Companies Hold Significant Positions In The Alpha Mannosidosis Market?

Major companies operating in the companion animal arthritis market are Zoetis Inc., Merck Animal Health, Boehringer Ingelheim, Bayer Animal Health, Vetoquinol, Ceva Santé Animale, Dechra Pharmaceuticals, PetMed Express, Pet Health Solutions, VetriScience, Canine Arthritis Management, Integrative Pet Care, The Honest Kitchen, Vetri-Science Laboratories, Anivive Lifesciences, Nutramax Laboratories, Hill’s Pet Nutrition, Royal Canin, Medivet, Virbac, Canna-Pet, Lintbells, Allivet, Petlab Co.

Read the full companion animal arthritis market report here:

https://www.thebusinessresearchcompany.com/report/companion-animal-arthritis-global-market-report

Which Regions Are Projected To Dominate The Alpha Mannosidosis Market In The Coming Years?

North America was the largest region in the companion animal arthritis market in 2025. The regions covered in the companion animal arthritis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Alpha Mannosidosis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7772&type=smp

Browse Through More Reports Similar to the Global Companion Animal Arthritis Market 2026, By The Business Research Company

Canine Arthritis Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/canine-arthritis-treatment-global-market-report

Companion Animal Pharmaceuticals Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/companion-animal-pharmaceuticals-global-market-report

Animal Health Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-health-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the artificial intelligence (ai)-driven web scraping market from 2026–2035 with trusted insights from The Business Research Company

By how much is the Companion Animal Arthritis Market expected to grow between 2026 and 2030?

The companion animal arthritis market has experienced substantial growth in its size over recent years. This market is projected to expand from $4.07 billion in 2025 to $4.48 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 10.1%. The expansion observed in the historical period can be ascribed to several factors, including an increase in companion animal ownership, the extended lifespan of dogs and cats, heightened awareness regarding pet joint health, the development of veterinary care infrastructure, and the improved accessibility of anti-inflammatory medications.

The market for companion animal arthritis treatments is anticipated to experience substantial expansion over the forthcoming years. This market is projected to reach $6.62 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.2%. This expansion during the projection period stems from several factors, including the increasing trend of pet humanization, a heightened demand for sophisticated arthritis treatments, an expanding population of senior pets, the proliferation of online veterinary pharmacies, and advancements in combination therapies and supplements. Key developments anticipated within the forecast timeframe encompass an escalating incidence of age-related arthritis in companion animals, increased financial outlay by pet owners for chronic illness management, broader acceptance of nutraceuticals and joint supplements, a movement towards proactive diagnosis and preventative care, and a greater need for sustained pain relief options.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7772&type=smp

Which Drivers Are Influencing Market Acceleration In The Companion Animal Arthritis Market?

The increasing rate of pet adoption is projected to drive the expansion of the companion animal arthritis market. Pet adoption involves assuming guardianship of an animal from a rescue organization or prior owner, then offering it nourishment, care, and a secure environment. This increase in pet adoption stems from heightened emotional consciousness, as individuals increasingly seek camaraderie and psychological well-being by looking after animals. Treatments for companion animal arthritis facilitate pet adoption by reassuring prospective owners that age-related joint problems are manageable, thereby simplifying the care of older pets and enhancing their adoptability. As an illustration, in 2024, data from the Shelter Animals Count (SAC), a US-based nonprofit organization, reveals that dog adoption rates (percentage of adoptions relative to intakes) rose from 56% in 2023 to 57% in 2024. Consequently, the expanding trend of pet adoption is a major contributor to the development of the companion animal arthritis market.

What Leading Segments Are Studied In The Companion Animal Arthritis Market?

The companion animal arthritis market covered in this report is segmented –

1) By Type: Dogs, Cats, Other Types

2) By Indication: Osteoarthritis, Inflammatory Arthritis

3) By Treatment: Medication, Supplements, Other Treatments

4) By Distribution Channel: Veterinary Hospitals And Clinics, Retail Pharmacies, Online Stores, Other Distribution Channels

Subsegments:

1) By Dogs: Large Breed Dogs, Small Breed Dogs, Senior Dogs

2) By Cats: Domestic Cats, Senior Cats

3) By Other Types: Rabbits, Ferrets

Which Trends Are Expected To Influence The Companion Animal Arthritis Market In The Upcoming Years?

Leading companies in the companion animal arthritis market are increasingly concentrating on technological innovations, such as advanced therapeutic products and supplements, to offer pets effective pain relief and enhanced joint health, thereby ensuring a superior quality of life for older and arthritis-affected animals. Bonqat is a new medication developed for cats that aids in reducing anxiety during stressful situations, including travel or veterinary visits, without causing sedation. The product aims to calm felines, making interactions easier for them and their owners during trips or appointments. For instance, in April 2024, Zoetis Inc., a US-based company that manufactures medicine and vaccinations for pets and livestock, introduced Bonqat (pregabalin oral solution) for the alleviation of feline acute anxiety and fear linked to transportation and veterinary visits, which can pose a barrier to routine care. This oral solution can be mixed with food or given directly to the cat, simplifying administration for pet owners. The dosing is small (0.1 mL/kg), and a majority of cat owners have reported that its administration is easy.

Which Major Industry Participants Are Leading The Companion Animal Arthritis Market Growth?

Major companies operating in the companion animal arthritis market are Zoetis Inc., Merck Animal Health, Boehringer Ingelheim, Bayer Animal Health, Vetoquinol, Ceva Santé Animale, Dechra Pharmaceuticals, PetMed Express, Pet Health Solutions, VetriScience, Canine Arthritis Management, Integrative Pet Care, The Honest Kitchen, Vetri-Science Laboratories, Anivive Lifesciences, Nutramax Laboratories, Hill’s Pet Nutrition, Royal Canin, Medivet, Virbac, Canna-Pet, Lintbells, Allivet, Petlab Co.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/companion-animal-arthritis-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Companion Animal Arthritis Market?

North America was the largest region in the companion animal arthritis market in 2025. The regions covered in the companion animal arthritis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Companion Animal Arthritis Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7772&type=smp

Browse Through More Reports Similar to the Global Companion Animal Arthritis Market 2026, By The Business Research Company

Canine Arthritis Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/canine-arthritis-treatment-global-market-report

Companion Animal Pharmaceuticals Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/companion-animal-pharmaceuticals-global-market-report

Animal Health Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-health-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the companion animal arthritis market from 2025–2034 with trusted insights from The Business Research Company

How Is The Companion Animal Arthritis Market Size Expected To Expand Over 2029-2034?

The market encompassing arthritis treatments for companion animals has seen robust expansion lately, projected to increase from $3.72 billion in the year 2024 to $4.07 billion by 2025, reflecting a compound annual growth rate of 9.3%. This upward trajectory during the past period stems from several factors, notably a rise in pet retention, progress within veterinary medical science, and enhanced levels of public understanding and knowledge concerning the condition.

Anticipation is high for substantial expansion within the companion animal arthritis sector over the forthcoming years, projecting a market valuation reaching six billion dollars by 2029, fueled by a compound annual growth rate of 10.2%; this upward trajectory during the projection timeframe is largely being propelled by the simultaneously increasing age of the pet demographic, groundbreaking advancements in treatment modalities, the proliferation of personalized dietary plans, the integration of remote consultation services in animal healthcare, and the escalating trend of treating pets as family members.Key developments shaping this period are characterized by the increasing adoption of biological agents in veterinary practice, the deployment of digital health platforms, a rising focus on nutritional supplements and foods with specific health benefits, strategic alliances and cooperative ventures, the tangible effect of pet insurance uptake, a growing consumer preference for remedies rooted in nature and holistic approaches, and the progressive adoption of data-informed decision-making within veterinary services.Both Driver 1: Aging Pet Population and Driver 2: Innovations in Therapeutics are primary factors contributing substantially to this market upswing, while Trend 1: Biologics in Veterinary Medicine and Trend 2: Digital Health Solutions are noted as significant forces influencing industry direction within the forecast window.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7772&type=smp

Which Market Factors Are Fueling The Companion Animal Arthritis Industry Growth?

The escalating rate of animals being adopted is anticipated to boost the expansion of the market focused on arthritis in companion animals, as welcoming pets into a home often lessens feelings of stress, anxiety, and depression among owners. Adopting a pet involves obtaining an animal such as a dog, cat, or an exotic variety from a facility like a shelter or rescue organization, rather than purchasing one from a pet store, breeder, or private seller. As these animals age, they become susceptible to developing arthritis. For illustrative purposes, data from a survey conducted by The American Pet Products Association—a US organization operating not for profit—indicated that close to fifty percent of households in Britain owning pets brought home at least one new animal during the lockdown period, concurrently with eleven point three million people in the United States gaining new pets throughout the pandemic. Moreover, that same survey revealed that during the pandemic, a noticeable proportion of younger demographics adopted new animals, specifically sixteen percent of Generation Z participants and thirteen percent of millennials. Consequently, the growing propensity for pet adoption plays a substantial part in fueling the development of the companion animal arthritis market.

Which Categories Are Covered In The Companion Animal Arthritis Market Segmentation Analysis?

The companion animal arthritis market covered in this report is segmented –

1) By Type: Dogs, Cats, Other Types

2) By Indication: Osteoarthritis, Other Arthritis

3) By Treatment: Medication, Supplements, Other Treatments

4) By Distribution Channel: Veterinary Hospitals And Clinics, Retail Pharmacies, Online Stores, Other Distribution Channels

Subsegments:

1) By Dogs: Large Breed Dogs, Small Breed Dogs, Senior Dogs

2) By Cats: Domestic Cats, Senior Cats

3) By Other Types: Rabbits, Ferrets, Other Small Mammals

Which Market Trends Are Expected To Define The Future Of The Companion Animal Arthritis Market?

The key players within the companion animal arthritis sector are progressively centering their efforts on introducing forward-thinking solutions, including sophisticated treatment options and dietary aids, with the goal of delivering potent pain management and enhancing joint well-being for older pets or those afflicted by arthritis, thereby elevating their overall living standards.Bonqat represents a recently introduced pharmaceutical agent specifically formulated for felines; its function is to mitigate feelings of distress experienced during high-stress scenarios, such as trips or check-ups at the vet, without inducing drowsiness, thereby smoothing the experience for both the animal and its human companions.As an illustration, in April of 2024, the American firm Zoetis Inc., known for producing veterinary pharmaceuticals and immunizations, released Bonqat (a pregabalin liquid preparation) intended to relieve sharp anxiety and phobia in cats stemming from movement and veterinary examinations, obstacles that frequently impede standard medical attention.This liquid formulation possesses the convenience of being either incorporated into food or delivered directly to the pet, simplifying the process for those who care for them, and due to its minimal dosage requirement (a tenth of a milliliter per kilogram), numerous cat guardians have attested to the straightforward nature of its application.

Which Organizations Are At The Forefront Of The Companion Animal Arthritis Market?

Major companies operating in the companion animal arthritis market include Zoetis Inc., Merck Animal Health, Boehringer Ingelheim, Bayer Animal Health, Vetoquinol, Ceva Santé Animale, Dechra Pharmaceuticals, PetMed Express, Pet Health Solutions, VetriScience, Synlogic, Canine Arthritis Management, Integrative Pet Care, The Honest Kitchen, Vetri-Science Laboratories, Anivive Lifesciences, Pawsitively Posh Pets, Trifecta Natural, Nutramax Laboratories, Hill’s Pet Nutrition, Royal Canin, Medivet, Virbac, Canna-Pet, Fetch for Pets, Lintbells, Allivet, Petlab Co.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/companion-animal-arthritis-global-market-report

Which Geographic Areas Are Driving Strong Demand For The Companion Animal Arthritis Market?

North America was the largest region in the companion animal arthritis market in 2024. The regions covered in the companion animal arthritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=7772&type=smp

Browse Through More Reports Similar to the Global Companion Animal Arthritis Market 2025, By The Business Research Company

Veterinary Pain Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-pain-management-global-market-report

Veterinary Vaccines Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Veterinary Pharmaceuticals Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-pharmaceuticals-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Companion Animal Arthritis Market Growth in 2025?

The market size of companion animal arthritis has significantly expanded in the past few years. It is projected to escalate from $3.72 billion in 2024 to $4.08 billion in 2025 with a compound annual growth rate (CAGR) of 9.7%. The historical growth of this market is linked to the rise in pet ownership, progress in veterinary medicine, and enhanced awareness and education.

What Is the Forecast for the Companion Animal Arthritis Market Size Through 2029?

Anticipated to experience swift expansion in coming years, the companion animal arthritis market is projected to burgeon to $6.04 billion by 2029, with a compound annual growth rate (CAGR) of 10.3%. Factors contributing to this positive trend during the forecast period include an increase in elderly pets, advancements in therapeutics, tailored pet nutrition, the inclusion of telemedicine in veterinary care, and the shift towards treating pets in a more humane manner. Key trends during the same timeframe encompass the use of biologics in veterinary treatment, the surge in digital health solutions, the rise in nutraceuticals and functional foods, the influence of collaborations and partnerships, the impact of pet insurance, the growing consumer demand for more natural and holistic therapies, as well as the adoption of data-driven veterinary care.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7772&type=smp

What are the Key Market Players in Companion Animal Arthritis Market and How They’re Evolving?

Major companies operating in the companion animal arthritis market include Zoetis Inc., Merck Animal Health, Boehringer Ingelheim, Bayer Animal Health, Vetoquinol, Ceva Santé Animale, Dechra Pharmaceuticals, PetMed Express, Pet Health Solutions, VetriScience, Synlogic, Canine Arthritis Management, Integrative Pet Care, The Honest Kitchen, Vetri-Science Laboratories, Anivive Lifesciences, Pawsitively Posh Pets, Trifecta Natural, Nutramax Laboratories, Hill’s Pet Nutrition, Royal Canin, Medivet, Virbac, Canna-Pet, Fetch for Pets, Lintbells, Allivet, Petlab Co.

What Are the Primary Growth Drivers in the Companion Animal Arthritis Market?

The increase in pet adoptions is predicted to promote the expansion of the companion animal arthritis market. Adopting pets can alleviate stress, anxiety, and depression among other issues. Obtaining a pet like a dog or cat, or another exotic creature, from a rescue or shelter to which their former owners have relinquished them, rather than from a breeder, pet shop, or person, is the process of pet adoption. Once pets start aging, there is a possibility they may develop arthritis. A study by The American Pet Products Association, a nonprofit industry association in the US, revealed that almost half of pet-owning UK households adopted at least one new pet during the lockdown, with 11.3 million new pets welcomed into American homes during the pandemic. The survey further showed that 16% of Generation Z and 13% of millennials have brought a new pet home during the pandemic. Consequently, the surge in pet adoption greatly influences the increase in the companion animal arthritis market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7772&type=smp

What Are the Leading Segments in the Global Companion Animal Arthritis Industry?

The companion animal arthritis market covered in this report is segmented –

1) By Type: Dogs, Cats, Other Types

2) By Indication: Osteoarthritis, Other Arthritis

3) By Treatment: Medication, Supplements, Other Treatments

4) By Distribution Channel: Veterinary Hospitals And Clinics, Retail Pharmacies, Online Stores, Other Distribution Channels

Subsegments:

1) By Dogs: Large Breed Dogs, Small Breed Dogs, Senior Dogs

2) By Cats: Domestic Cats, Senior Cats

3) By Other Types: Rabbits, Ferrets, Other Small Mammals

What Are the Key Market Trends in the Companion Animal Arthritis Industry?

Leading businesses in the companion animal arthritis industry are putting a growing emphasis on technology advancements, specifically innovative therapeutic goods and supplements, to provide pet animals with efficient pain management and enhanced joint health. This ensures a better lifestyle for elderly and arthritis-stricken animals. Bonqat, an innovative calming medication for cats, reduces anxiety in stressful situations without sedating the animal. This product simplifies scenarios such as travel or vet visits for both cats and their caretakers. For instance, in April 2024, Zoetis Inc., an American company specializing in the production of pet and livestock medications and vaccines, introduced Bonqat (pregabalin oral solution). This product specifically helps to alleviate transportation-related and vet visit-induced anxiety and fear in cats, which could potentially prevent them from receiving regular care. This oral solution can be mixed in food or directly fed to cats, simplifying the process for pet owners. Its dosage operates at a minimal level (0.1 mL/kg), and a large number of cat owners have reported ease of administration.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/companion-animal-arthritis-global-market-report

What Is the Regional Outlook for the Companion Animal Arthritis Market?

North America was the largest region in the companion animal arthritis market in 2024. The regions covered in the companion animal arthritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7772

This Report Delivers Insight On:

1. How big is the companion animal arthritis market, and how is it changing globally?

2. Who are the major companies in the companion animal arthritis market, and how are they performing?

3. What are the key opportunities and risks in the companion animal arthritis market right now?

4. Which products or customer segments are growing the most in the companion animal arthritis market?

5. What factors are helping or slowing down the growth of the companion animal arthritis market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the companion animal arthritis industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Fast Is The Companion Animal Arthritis Market Expected to Grow Between 2025 And 2029?

The size of the market for arthritis treatment for companion animals has shown robust growth in the past few years. It is projected to expand from $3.72 billion in 2024 to $4.08 billion in 2025, experiencing a compound annual growth rate (CAGR) of 9.7%. The historical growth rate is credited to factors such as expanding pet ownership, advancements in the field of veterinary medicine, as well as increased awareness and educational efforts.

Expectations are high for the companion animal arthritis market to experience swift expansion in the coming years. Its valuation is predicted to reach $6.04 billion by 2029, at a compound annual growth rate (CAGR) of 10.3%. The projected growth during the forecast period can be credited to factors such as an aging pet demographic, advancements in therapeutics, personalized pet nutrition, the application of telemedicine in veterinary healthcare, and the increasing humanization of pets. Key trends for the forecast phase encompass the use of biologics in veterinary medicine, digital health solutions, nutraceuticals and functional food products, collaborations and partnerships within the industry, the influence of pet insurance, growing consumer preference for natural and holistic treatments, and a data-driven approach to veterinary care.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7772&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Companion Animal Arthritis Market?

The increase in pet adoption is predicted to boost the growth of the companion animal arthritis market. Adopting pets has been found to mitigate stress, anxiety, depression, and other mental health issues. Instead of purchasing from pet stores, breeders, or other people, adoption involves taking in a dog, cat, or other exotic animal that their former owners have surrender to an animal shelter or rescue. When pets begin to age, the likelihood of arthritis development increases. For instance, The American Pet Products Association, a nonprofit industry organization based in the US, reported that about half of British households with pets added at least one new animal while the nation was under lockdown. Moreover, around 11.3 million Americans welcomed new pets during the pandemic. Additionally, the survey found that 16% of Generation Z respondents and 13% of millennials said they had adopted a new pet during the pandemic. As such, the growing practice of pet adoption plays a significant role in the expansion of the companion animal arthritis market.

Which Key Market Segments Comprise the Companion Animal Arthritis Market and Drive Its Revenue Growth?

The companion animal arthritis market covered in this report is segmented –

1) By Type: Dogs, Cats, Other Types

2) By Indication: Osteoarthritis, Other Arthritis

3) By Treatment: Medication, Supplements, Other Treatments

4) By Distribution Channel: Veterinary Hospitals And Clinics, Retail Pharmacies, Online Stores, Other Distribution Channels

Subsegments:

1) By Dogs: Large Breed Dogs, Small Breed Dogs, Senior Dogs

2) By Cats: Domestic Cats, Senior Cats

3) By Other Types: Rabbits, Ferrets, Other Small Mammals

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=7772&type=smp

Which Areas Are Leading Regions in the Companion Animal Arthritis Market Expansion Across the Globe?

North America was the largest region in the companion animal arthritis market in 2024. The regions covered in the companion animal arthritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Key Market Trends in theCompanion Animal Arthritis Market Over the Coming Years?

Leading businesses in the companion animal arthritis sector are escalating their focus on technological progress, such as enhanced therapeutic items and supplements. Their goal is to offer pets effective alleviation from pain, better joint health, and a superior quality of life, especially for aged and arthritis-stricken animals. Bonqat is a newly developed medication designed for felines that minimizes anxiety in stressful situations, like travel or vet visits, without causing any sedative effects. It is intended to soothe the cats, thus making it less stressful for them and their caregivers during journeys or check-ups. In April 2024, Zoetis Inc., an American firm that produces medicines and vaccines for pets and livestock, introduced Bonqat (pregabalin oral solution). It’s meant for relieving acute anxiety and fear in cats during transportation and veterinary appointments, which often pose a challenge to regular care. This oral solution can be given directly to the cat or mixed with its food, simplifying the administration process for the pet parents. With its small dosage (0.1 mL/kg), most cat owners have found it easy to administer.

View the full report here:

https://www.thebusinessresearchcompany.com/report/companion-animal-arthritis-global-market-report

How Is the Companion Animal Arthritis Market Conceptually Defined?

The companion animal arthritis refers to a condition involving inflammation of one or more joints in companion animals such as cats, dogs, and other exotic animals. Companion animal arthritis develops in the bones when the cartilage between joints becomes rougher and more worn, forcing the bone surfaces to rub against one another.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7772

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Companion Animal Arthritis Market?

The increasing popularity of pet adoption is projected to drive the expansion of the companion animal arthritis market. Adopting a pet can alleviate stress, anxiety, and depression among other benefits. Unlike purchasing from a pet store, breeder, or another person, pet adoption involves taking in a dog, cat, or other exotic animal given up by their previous owners to a shelter or rescue. These pets, once they begin to age, are susceptible to arthritis. For example, according to a study by The American Pet Products Association, a non-profit organization in the US, half the British households with pets adopted at least one new animal during the lockdown. Moreover, 11.3 million Americans brought home new pets amidst the pandemic. In this same study, it was reported that 16% of Generation Z participants and 13% of millennials adopted a new pet during the pandemic. Hence, the surging rate of pet adoption is playing a significant role in the growth of the companion animal arthritis market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7772&type=smp

How Has the Companion Animal Arthritis Market Evolved in Recent Years, and What are the Growth Projections for the Forecast Period?

Over the past few years, the market size for companion animal arthritis treatments has experienced substantial growth. It is projected to increase from $3.72 billion in 2024 and expand to $4.08 billion in 2025, with a compound annual growth rate (CAGR) of 9.7%. The growth observed in the historic period is a result of several factors, including the rise in pet adoption, advancements made in the field of veterinary medicine, as well as increased education and awareness.

Over the coming years, the companion animal arthritis market is expected to experience robust growth, with projections indicating a market value of $6.04 billion by 2029, at a compound annual growth rate (CAGR) of 10.3%. This anticipated growth within the forecast period is primarily due to factors such as an ageing pet population, advancements in therapeutics, personalization in pet nutrition, and the application of telemedicine in veterinary practices. Other notable trends that are anticipated to influence the market during the forecast period are the use of biologicals in veterinary medicine, digital healthcare solutions, functional foods and nutraceuticals, strategic collaborations and partnerships, the impact of pet insurance, increasing consumer demand for natural and holistic treatments, and the utilization of data in veterinary care.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7772

What Are the Key Market Innovations in theCompanion Animal Arthritis Market Over the Coming Years?

The leading businesses in the companion animal arthritis market are paying more attention to technological developments, such as sophisticated therapeutic items and supplements. The goal is to offer pets effective pain management and enhanced joint health, thereby ensuring a better standard of living for older and arthritis-afflicted animals. Bonqat is a newly formulated drug for cats designed to lessen anxiety in high stress situations such as travelling or vet check-ups, without inducing sedation. The product is purposed to soothe cats, easing the experience for both them and their owners during outings or check-ups. For example, in April 2024, Zoetis Inc., a U.S.-based firm specializing in the production of medication and vaccines for pets and livestock, introduced Bonqat (pregabalin oral solution). Its primary function is to relieve the acute anxiety and fear cats experience linked to transportation and veterinary visits, which can become an obstacle to their regular care. This oral solution can be added to food or fed directly to the cat, simplifying the administration process for pet owners. The dosage is minimal (0.1 mL/kg), and most cat-owning respondents have stated that the process of giving the medication is straightforward.

Who Are the Top Companies Driving Innovation and Growth in theCompanion Animal Arthritis Market?

Major companies operating in the companion animal arthritis market include Zoetis Inc., Merck Animal Health, Boehringer Ingelheim, Bayer Animal Health, Vetoquinol, Ceva Santé Animale, Dechra Pharmaceuticals, PetMed Express, Pet Health Solutions, VetriScience, Synlogic, Canine Arthritis Management, Integrative Pet Care, The Honest Kitchen, Vetri-Science Laboratories, Anivive Lifesciences, Pawsitively Posh Pets, Trifecta Natural, Nutramax Laboratories, Hill’s Pet Nutrition, Royal Canin, Medivet, Virbac, Canna-Pet, Fetch for Pets, Lintbells, Allivet, Petlab Co.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/companion-animal-arthritis-global-market-report

Which Key Market Segments Comprise the Companion Animal Arthritis Market and Drive Its Revenue Growth?

The companion animal arthritis market covered in this report is segmented –

1) By Type: Dogs, Cats, Other Types

2) By Indication: Osteoarthritis, Other Arthritis

3) By Treatment: Medication, Supplements, Other Treatments

4) By Distribution Channel: Veterinary Hospitals And Clinics, Retail Pharmacies, Online Stores, Other Distribution Channels

Subsegments:

1) By Dogs: Large Breed Dogs, Small Breed Dogs, Senior Dogs

2) By Cats: Domestic Cats, Senior Cats

3) By Other Types: Rabbits, Ferrets, Other Small Mammals

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=7772&type=smp

Which Regions Are Emerging as Leaders in the Companion Animal Arthritis Market?

North America was the largest region in the companion animal arthritis market in 2024. The regions covered in the companion animal arthritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Gobal Companion Animal Arthritis Maret 2025, By The Business Research Company:

Veterinary Anti-infectives Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

Veterinary Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Veterinary Pharmaceuticals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-pharmaceuticals-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the companion animal arthritis market right now?

The market size of companion animal arthritis has seen significant expansion in recent periods. It is projected to rise from $3.72 billion in 2024 to $4.08 billion in 2025, boasting a compound annual growth rate (CAGR) of 9.7%. The spike in growth during the previous period can be credited to factors like a rise in pet ownership, progress in veterinary medicine, and improved awareness and education.

How fast Is the companion animal arthritis market expected to grow, and what’s its future value?

The market size of companion animal arthritis is projected to undergo swift expansion in the upcoming years. It’s anticipated to increase to $6.04 billion in 2029, with a compound annual growth rate (CAGR) of 10.3%. This expected growth during the forecast period is largely due to factors such as an aging pet population, innovations in therapeutics, personalized nutrition, the role of telemedicine in veterinary care, and the increasing humanization of pets. The period’s major trends include the use of biologics in veterinary medicine, digital health solutions, nutraceuticals, and functional foods, collaborations and partnerships, the effects of pet insurance, the consumer demand for natural and holistic therapies, and data-driven veterinary care.

Get your companion animal arthritis market report here!

https://www.thebusinessresearchcompany.com/report/companion-animal-arthritis-global-market-report

What are the leading drivers of growth in the companion animal arthritis market?

The upward trend in pet adoption is anticipated to boost the expansion of the companion animal arthritis market. Adopting pets can minimize stress, anxiety, depression, among others. Essentially, pet adoption involves acquiring an animal like a dog, cat, or rare animal that the initial owners have surrendered to a shelter or rescue instead of acquiring one from a pet store, breeder, or another person. Pets are at risk of arthritis as they age. According to a study by The American Pet Products Association, a not-for-profit industry association based in the US, around half of the pet-owning households in Britain added at least one new pet during the lockdown. Also, 11.3 million Americans got new pets during the outbreak. Further, in the survey, about 16% of Generation Z and 13% of millennials said they had gotten a new pet during the pandemic. Consequently, the growing trend of pet adoption plays a significant role in the expansion of the companion animal arthritis market.

What are the key segments defining the companion animal arthritis market?

The companion animal arthritis market covered in this report is segmented –

1) By Type: Dogs, Cats, Other Types

2) By Indication: Osteoarthritis, Other Arthritis

3) By Treatment: Medication, Supplements, Other Treatments

4) By Distribution Channel: Veterinary Hospitals And Clinics, Retail Pharmacies, Online Stores, Other Distribution Channels

Subsegments:

1) By Dogs: Large Breed Dogs, Small Breed Dogs, Senior Dogs

2) By Cats: Domestic Cats, Senior Cats

3) By Other Types: Rabbits, Ferrets, Other Small Mammals

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7772&type=smp

Who are the key players steering the development of the companion animal arthritis market?

Major companies operating in the companion animal arthritis market include Zoetis Inc., Merck Animal Health, Boehringer Ingelheim, Bayer Animal Health, Vetoquinol, Ceva Santé Animale, Dechra Pharmaceuticals, PetMed Express, Pet Health Solutions, VetriScience, Synlogic, Canine Arthritis Management, Integrative Pet Care, The Honest Kitchen, Vetri-Science Laboratories, Anivive Lifesciences, Pawsitively Posh Pets, Trifecta Natural, Nutramax Laboratories, Hill’s Pet Nutrition, Royal Canin, Medivet, Virbac, Canna-Pet, Fetch for Pets, Lintbells, Allivet, Petlab Co.

What emerging trends are influencing the growth of the companion animal arthritis market?

Leading businesses in the companion animal arthritis market are progressively adopting technological advancements like innovative therapeutic items and supplements. The goal is to offer efficient pain management and enhanced joint wellbeing for older or arthritis-stricken pets, ensuring they have an improved standard of living. A newly invented medication for cats, Bonqat, aims to lessen their anxiety in high-stress circumstances like travel or vet appointments without a sedating effect. The product’s purpose is to soothe cats, facilitating these occasions for both them and their caretakers. For instance, Zoetis Inc., a U.S.-based firm that produces medicines and vaccines for pets and livestock, introduced Bonqat (pregabalin oral solution) in April 2024. This solution alleviates acute anxiety and fear related to transportation and veterinary visits in cats, which can often hinder routine care. The solution can be mixed with food or administered directly, simplifying the task for pet owners. The required dosage is small (0.1 mL/kg), and most cat parents find it convenient to administer.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7772

Which regions are most influential in expanding the companion animal arthritis market?

North America was the largest region in the companion animal arthritis market in 2024. The regions covered in the companion animal arthritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Veterinary Anti-infectives Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

Veterinary Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Veterinary Pharmaceuticals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-pharmaceuticals-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Future CAGR is Anticipated for the Companion Animal Arthritis Market Over the 2025–2034 Period?

The market size for companion animal arthritis has seen a robust expansion in the past few years. The market value is expected to increase from $3.72 billion in 2024 to $4.08 billion in 2025, witnessing a compound annual growth rate (CAGR) of 9.7%. The substantial growth during the historical period is linked to factors such as rise in pet adoption, progress in veterinary medicine, enhanced awareness, and education.

The market for arthritis treatment in companion animals is anticipated to undergo swift expansion in the coming years. It’s forecasted to escalate to $6.04 billion by 2029, with a compound annual growth rate (CAGR) of 10.3%. This predicted growth during the forecast period can be linked to factors such as the increasing age of pet populations, advancements in therapeutic options, personalized pet nutrition, the integration of telemedicine in veterinary services, and the humanization of pets. Key trends expected to shape the market during this time comprise the inclusion of biologic medicines in veterinary practice, the advent of digital health solutions, the rise of nutraceuticals and functional foods, the role of collaborations and partnerships, the influence of pet insurance, the increasing consumer demand for natural and holistic therapies, and the implementation of data-driven veterinary care.

What Factors Are Propelling the Growth of the companion animal arthritis Market from 2025 to 2034?

The upward trajectory of pet adoption is anticipated to fuel the expansion of the companion animal arthritis market. Adopting pets aids in curbing stress, anxiety, depression, etc. This is a process of obtaining dogs, cats, or other exotics from shelters or rescues, particularly those that have been deserted by their previous owners, rather than directly from pet stores or breeders. It’s crucial to note that as pets age, they run the risk of developing arthritis. For example, The American Pet Products Association, a non-profit industry association based in the US, carried out a survey which revealed that roughly half of UK households with pets welcomed at least one new animal during the lockdown, whilst about 11.3 million Americans brought new pets home during the pandemic. Moreover, the poll also indicated that 16% of Generation Z and 13% of millennials adopted a new pet during this noteworthy period. Hence, the escalation in pet adoption significantly propels the expansion of the companion animal arthritis market.

Explore Comprehensive Insights Into The Global Companion Animal Arthritis Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7772&type=smp

Who Are the Influential Players Fueling Innovation and Growth in the Companion Animal Arthritis Market?

Major companies operating in the companion animal arthritis market include:

• Zoetis Inc._x000D_

• Merck Animal Health_x000D_

• Boehringer Ingelheim_x000D_

• Bayer Animal Health_x000D_

• Vetoquinol_x000D_

What Impact Are Industry Trends Having on the Companion Animal Arthritis Market’s Future Prospects?

Leading firms in the companion animal arthritis industry are increasingly shifting their focus towards technological advancements in order to produce enhanced therapeutic items and supplements. The aim is to ensure pain reduction and improved joint health for pets, thereby enhancing the quality of life for older animals and those afflicted by arthritis. Bonqat, a newly developed medication for cats, assists in minimizing anxiety during high-stress situations, like travelling or visiting the vet, without any sedative effects. The product’s purpose is to soothe cats, easing their stress and that of their owners during travel or appointments. In April 2024, for example, Zoetis Inc., a US-based company known for the manufacture of animal medication and vaccinations, introduced Bonqat (pregabalin oral solution) to address acute anxiety and fear in cats in relation to transport and veterinary visits, circumstances which typically act as obstacles to regular care. This oral solution can be mixed with meals or given straight to the cat, making it simpler for pet owners to administer. The dose is small (0.1 mL/kg), and a large number of cat owners claim it is easy to administer.

Secure Your Global Companion Animal Arthritis Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/companion-animal-arthritis-global-market-report

Which Key Segments Define the Structure of the Companion Animal Arthritis Market and Their Growth Potential?

The companion animal arthritis market covered in this report is segmented –

1) By Type: Dogs, Cats, Other Types

2) By Indication: Osteoarthritis, Other Arthritis

3) By Treatment: Medication, Supplements, Other Treatments

4) By Distribution Channel: Veterinary Hospitals And Clinics, Retail Pharmacies, Online Stores, Other Distribution Channels

Subsegments:

1) By Dogs: Large Breed Dogs, Small Breed Dogs, Senior Dogs

2) By Cats: Domestic Cats, Senior Cats

3) By Other Types: Rabbits, Ferrets, Other Small Mammals

What Regions Are Leading the Growth Trajectory of the Companion Animal Arthritis Market?

North America was the largest region in the companion animal arthritis market in 2024. The regions covered in the companion animal arthritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

How Do Experts Define the Scope of the Companion Animal Arthritis Market?

The companion animal arthritis refers to a condition involving inflammation of one or more joints in companion animals such as cats, dogs, and other exotic animals. Companion animal arthritis develops in the bones when the cartilage between joints becomes rougher and more worn, forcing the bone surfaces to rub against one another.

Browse Through More Similar Reports By The Business Research Company:

Veterinary Anti-infectives Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

Veterinary Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Veterinary Pharmaceuticals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-pharmaceuticals-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: